Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

OXURION - Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO ...

CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company focused on the development of innovative therapies, announces the signing of a binding ...

Four medical affairs leaders reveal what’s working (and what’s not) when it comes to engaging time-starved HCPs in 2025.

Government funding in nanotechnology research and favorable R&D incentives is fast-tracking market growth across developed economies. INDORE, INDIA, May 21, 2025 /EINPresswire.com/ -- Nanomaterials ...

Q4 2025 Earnings Call Transcript May 15, 2025 Doximity, Inc. beats earnings expectations. Reported EPS is $0.38, expectations ...

Discover the top 3 undervalued Diversified Consumer Services stocks for Thursday, May 15 based on AAII’s Stock Grades.

Three households on the same street grapple with aging in their homes — reflecting some common conundrums aging Americans ...

We have a session with Microbix to discuss the Q2 results they put out this morning. You can find those on the company's website on SEDAR and the press release probably was sent to your inbox. Let's ...

Shares of NeurAxis, Inc. NRXS have gained 13.3% since the company reported its earnings for the quarter ended March 31, 2025.

From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

The first quarter of 2025 was both strategically and clinically significant for Neola Medical. The company strengthened its financial position through a successful directed share issue of approximatel ...